📖

parkinsons-disease

wiki page Created: 2026-04-02 04:21:26 By: import Quality: 70% ✓ SciDEX ID: wiki-parkinsons-disease
Related Entities
parkinsons-disease
Metadata
entity_typedisease
neurowiki_urlhttps://neurowiki.xyz/wiki/diseases/parkinsons-disease
summaryNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (96)
mentions🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera97%
mentions🧫AAV-LRRK2 IND-Enabling Study Design97%
mentions🧫AAV Serotype Comparison for LRRK2 Knockdown in PD97%
mentions🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back97%
mentions🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio97%
mentions🧫Computational Modeling of Alpha-Synuclein Propagation in PD97%
mentions🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation97%
mentions🧫Alpha-Synuclein Seed Amplification Assay Validation97%
mentions🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation97%
mentions🧫Antiviral Therapy Trial for Parkinson's Disease97%
mentions🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&97%
mentions🧫Axonal Transport Dysfunction Validation in Parkinson's 97%
mentions🧫cGAS-STING Pathway Validation Study in Parkinson's Dise97%
mentions🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 97%
mentions🧫Combination Therapy Sequencing in Parkinson's Disease97%
mentions🧫CRISPR Gene Correction Approaches for CBS/PSP97%
mentions🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa97%
mentions🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#97%
mentions🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i97%
mentions🧫Endocannabinoid System Dysfunction Validation in Parkinson&#97%
mentions🧫Epigenetic Dysregulation Validation in Parkinson's Dise97%
mentions🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De97%
mentions🧫Exercise-BDNF-Mitophagy Biomarker Study in PD97%
mentions🧫Ferroptosis Validation in Parkinson's Disease97%
mentions🧫GLP-1 Agonist Neuroprotection Mechanism in PD97%
mentions🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&97%
mentions🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me97%
mentions🧫Cytochrome Therapeutics97%
mentions🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson97%
mentions🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown97%
mentions🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design97%
mentions🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne97%
mentions🧫Macroautophagy Dysfunction in PD - Experiment Design97%
mentions🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P97%
mentions🧫Validation: Membrane-Nucleation in iPSC Neurons97%
mentions🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr97%
mentions🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 97%
mentions🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag97%
mentions🧫MLCS Quantification in Parkinson's Disease97%
mentions🧫Experiment: Multi-Ethnic PD GWAS97%
mentions🧫Multiscale Computational Modeling of Protein Aggregation Kin97%
mentions🧫Neural Oscillation Dysfunction Validation in Parkinson'97%
mentions🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise97%
mentions🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper97%
mentions🧫Non-Motor Symptom Progression in Parkinson's Disease — 97%
mentions🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#97%
mentions🧫Parkinson's Disease Subtype Classification — Precision 97%
mentions🧫Peroxisomal Dysfunction Validation in Parkinson's Disea97%
mentions🧫Peroxisome Dysfunction Validation in Parkinson's Diseas97%
mentions🧫Prodromal Parkinson's Disease Biomarker Development — E97%
mentions🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin97%
mentions🧫Purinergic Signaling Dysfunction Validation in Parkinson97%
mentions🧫Regulated Necrosis Validation Study in Parkinson's Dise97%
mentions🧫Sirtuin Dysfunction Validation in Parkinson's Disease97%
mentions🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D97%
mentions🧫Stress Granule Dysfunction Validation in Parkinson's Di97%
mentions🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&97%
mentions🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki97%
mentions🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim97%
related🔬What are the mechanisms underlying what are the mechanisms b70%
related🧪Enteric Nervous System Prion-Like Propagation Blockade60%
related🧪Gut Barrier Permeability-α-Synuclein Axis Modulation60%
related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation60%
related🧪Microbial Inflammasome Priming Prevention60%
related🧪Vagal Afferent Microbial Signal Modulation60%
related🧪Enteric Nervous System Prion-Like Propagation Blockade54%
related🧪Gut Barrier Permeability-α-Synuclein Axis Modulation54%
related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation54%
related🧪Microbial Inflammasome Priming Prevention54%
related🧪Vagal Afferent Microbial Signal Modulation54%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%
related🔬What cell types are most vulnerable in Alzheimers Disease ba50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
related🔬What are the most promising therapeutic strategies for targe50%
related🔬How to break the GBA-alpha-synuclein bidirectional loop for 50%
related🔬Can gut-brain axis modulation prevent or slow Alzheimer'50%
related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph50%
mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%
mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%
mentions🔬What are the most promising therapeutic strategies for targe40%
mentions🔬Can gut-brain axis modulation prevent or slow Alzheimer'40%
mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%